to 2007. Patients enrolled in the program had had a glomerular filtration rate (GFR) <60 ml/min/1.73 m 2 , proteinuria >300 mg/day, or diabetes with micro albuminuria, for at least 3 months. Overall, 80% of patients had stage 1-3 CKD and 17% had stage 1-2 CKD.
Inclusion in the prevention program resulted in improved blood pressure control, improved glycemic control, and reduced levels of cholesterol and triglycerides. Importantly, during the first 3 months after entry, mean GFR increased from 42.7 ml/min/1.73 m 2 to 48.2 ml/min/1.73 m 2 (P <0.05), and the rate of deterioration of renal function in patients with stage 2-3 CKD decreased from -3.1 ml/min/year to -0.13 ml/min/year.
The data also indicate that strategies aimed at education and raising awareness of CKD risk factors are bearing fruit. Among patients referred to the program in the period [2004] [2005] 35 
